Answers are grounded in this paper and cite their sources.
This research demonstrates robust antibacterial effects and aids in abscess repair using VO₂ nanoparticles combined with photothermal therapy, suggesting a novel treatment for multidrug-resistant infections.
Abstract Multidrug-resistant (MDR) bacterial infections represent a major public health threat, urgently demanding novel therapeutic strategies. Nanozymes, offering a unique mechanism of action less prone to inducing resistance, have emerged as promising antibacterial agents. They not only mimic natural enzyme catalysis to generate reactive oxygen species (ROS) but also enable synergistic effects when combined with other modalities. However, balancing straightforward synthesis with potent antibacterial efficacy remains challenging. This study introduces easily synthesized VO₂ nanoparticles that effectively mimic natural enzyme activity. When combined with photothermal therapy (PTT), these nanoparticles generate substantial ROS, achieving robust antibacterial effects and significantly impacting biofilm formation and eradication. Furthermore, owing to their favorable biocompatibility, VO₂ modulates relevant macrophage markers, facilitating abscess wound repair. In summary, the developed photothermal-chemodynamic therapy (PTT-CDT) utilizing VO₂ nanoparticles presents a novel strategy for combating MDR bacterial infections.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: